Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1219

1.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2019 Dec;30(12):2012. doi: 10.1093/annonc/mdz224. Epub 2020 Jan 8. No abstract available.

PMID:
31987308
2.

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.

Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph R, Weber JS, Dronca R, Mitchell TC, Patnaik A, Zarour HM, Joshua AM, Zhao Q, Jensen E, Ahsan S, Ibrahim N, Ribas A.

Ann Oncol. 2019 Apr;30(4):582-588. doi: 10.1093/annonc/mdz011. Epub 2019 Dec 4.

PMID:
31987275
3.

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.

Long GV, Flaherty KT, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Chiarion-Sileni V, Lebbe C, Mandalá M, Millward M, Arance A, Bondarenko I, Haanen JBAG, Hansson J, Utikal J, Ferraresi V, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane SR, Legos JJ, Mookerjee B, Grob JJ.

Ann Oncol. 2019 Nov;30(11):1848. doi: 10.1093/annonc/mdz221. Epub 2020 Jan 8. No abstract available.

PMID:
31987099
4.

One or Two Immune Checkpoint Inhibitors?

Robert C, Lanoy E, Besse B.

Cancer Cell. 2019 Dec 9;36(6):579-581. doi: 10.1016/j.ccell.2019.11.005.

PMID:
31951559
5.

Adaptation of Biotrophic Leaf Pathogens to Fertilisation-Mediated Changes in Plant Traits: A Comparison of the Optimisation Principle to Invasion Fitness.

Précigout PA, Robert C, Claessen D.

Phytopathology. 2020 Jan 13. doi: 10.1094/PHYTO-08-19-0317-R. [Epub ahead of print]

PMID:
31928514
6.

Biosafety Evaluation of Equine Umbilical Cord-Derived Mesenchymal Stromal Cells (UC-MSCs) by Systematic Pathogen Screening in Peripheral Maternal Blood and Paired UC-MSCs.

Denys M, Léon A, Robert C, Saulnier N, Josson-Schramme A, Legrand L, Wimel L, Maddens S, Pronost S.

Biopreserv Biobank. 2020 Jan 3. doi: 10.1089/bio.2019.0071. [Epub ahead of print]

PMID:
31904273
7.

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600-mutant melanoma.

Ascierto PA, Dummer R, Gogas HJ, Flaherty KT, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, de Groot JWB, Loquai C, Gollerkeri A, Pickard MD, Robert C.

Eur J Cancer. 2020 Jan 2;126:33-44. doi: 10.1016/j.ejca.2019.11.016. [Epub ahead of print]

8.

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial.

Eggermont AMM, Kicinski M, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, Krepler C, Ibrahim N, Marreaud S, van Akkooi A, Robert C, Suciu S.

JAMA Oncol. 2020 Jan 2. doi: 10.1001/jamaoncol.2019.5570. [Epub ahead of print]

PMID:
31895407
9.

Antepartum Drug Dependence and Pregnancy- or Birth-related Complications: A Cross-sectional Study of 19 Million Inpatients.

Ahmad N, Robert CA, Jampa A, Ashraf S, Patel RS.

Cureus. 2019 Nov 10;11(11):e6117. doi: 10.7759/cureus.6117.

10.

Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting.

Herrscher H, Robert C.

Curr Opin Oncol. 2019 Dec 23. doi: 10.1097/CCO.0000000000000610. [Epub ahead of print]

PMID:
31876547
11.

Adjuvant therapy versus watch-and-wait post surgery for stage III melanoma: a multicountry retrospective chart review.

Mohr P, Kiecker F, Soriano V, Dereure O, Mujika K, Saiag P, Utikal J, Koneru R, Robert C, Cuadros F, Chacón M, Villarroel RU, Najjar YG, Kottschade L, Couselo EM, Koruth R, Guérin A, Burne R, Ionescu-Ittu R, Perrinjaquet M, Zager JS.

Melanoma Manag. 2019 Oct 4;6(4):MMT33. doi: 10.2217/mmt-2019-0015.

12.

KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.

Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM.

Future Oncol. 2020 Jan;16(3):4429-4438. doi: 10.2217/fon-2019-0666. Epub 2019 Dec 24.

13.

LD-annot: A Bioinformatics Tool to Automatically Provide Candidate SNPs With Annotations for Genetically Linked Genes.

Prunier J, Lemaçon A, Bastien A, Jafarikia M, Porth I, Robert C, Droit A.

Front Genet. 2019 Nov 26;10:1192. doi: 10.3389/fgene.2019.01192. eCollection 2019.

14.

An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells.

Shen S, Faouzi S, Bastide A, Martineau S, Malka-Mahieu H, Fu Y, Sun X, Mateus C, Routier E, Roy S, Desaubry L, André F, Eggermont A, David A, Scoazec JY, Vagner S, Robert C.

Nat Commun. 2019 Dec 16;10(1):5713. doi: 10.1038/s41467-019-13360-6.

15.

Impact of Seasonal and Temperature-Dependent Variation in Root Defense Metabolites on Herbivore Preference in Taraxacum officinale.

Huang W, Bont Z, Hervé MR, Robert CAM, Erb M.

J Chem Ecol. 2020 Jan;46(1):63-75. doi: 10.1007/s10886-019-01126-9. Epub 2019 Dec 12.

16.

Culture of Methanogenic Archaea from Human Colostrum and Milk.

Togo AH, Grine G, Khelaifia S, des Robert C, Brevaut V, Caputo A, Baptiste E, Bonnet M, Levasseur A, Drancourt M, Million M, Raoult D.

Sci Rep. 2019 Dec 9;9(1):18653. doi: 10.1038/s41598-019-54759-x.

17.

Vegetable lecithins: A review of their compositional diversity, impact on lipid metabolism and potential in cardiometabolic disease prevention.

Robert C, Couëdelo L, Vaysse C, Michalski MC.

Biochimie. 2020 Feb;169:121-132. doi: 10.1016/j.biochi.2019.11.017. Epub 2019 Nov 28. Review.

PMID:
31786232
18.

A Rising Hope of an Artificial Heart: Left Ventricular Assisted Device - Outcome, Convenience, and Quality of Life.

Thiha S, Zaidi ARZ, Robert CA, Abbas MK, Malik BH.

Cureus. 2019 Sep 10;11(9):e5617. doi: 10.7759/cureus.5617. Review.

19.

Society of pediatric liver transplantation: Current registry status 2011-2018.

Elisofon SA, Magee JC, Ng VL, Horslen SP, Fioravanti V, Economides J, Erinjeri J, Anand R, Mazariegos GV; Society of Pediatric Liver Transplantation Research Group.

Pediatr Transplant. 2020 Feb;24(1):e13605. doi: 10.1111/petr.13605. Epub 2019 Nov 3.

PMID:
31680409
20.

[Which patient for TAVI in 2019?]

Cayla G, Schmutz L, Soullier C, Ricci JE, Robert C, Cambon-Viala M, Goger AL, Lattuca B.

Ann Cardiol Angeiol (Paris). 2019 Dec;68(6):405-409. doi: 10.1016/j.ancard.2019.10.002. Epub 2019 Oct 25. French.

PMID:
31668846
21.

Plant defense resistance in natural enemies of a specialist insect herbivore.

Zhang X, van Doan C, Arce CCM, Hu L, Gruenig S, Parisod C, Hibbard BE, Hervé MR, Nielson C, Robert CAM, Machado RAR, Erb M.

Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23174-23181. doi: 10.1073/pnas.1912599116. Epub 2019 Oct 28.

22.

Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Verver D, Poirier-Colame V, Tomasic G, Cherif-Rebai K, Grunhagen DJ, Verhoef C, Suciu S, Robert C, Zitvogel L, Eggermont AMM.

Oncoimmunology. 2019 Sep 6;8(11):e1660121. doi: 10.1080/2162402X.2019.1660121. eCollection 2019.

PMID:
31646109
23.

Transcranial Magnetic Stimulation for Major Depressive Disorder in Pregnancy: A Literature Review.

Shah MR, Jampa A, Kaur M, Robert CA, Patel RS.

Cureus. 2019 Aug 19;11(8):e5431. doi: 10.7759/cureus.5431. Review.

24.

Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients.

Herms F, Lambert J, Grob JJ, Haudebourg L, Bagot M, Dalac S, Dutriaux C, Guillot B, Jeudy G, Mateus C, Monestier S, Mortier L, Poulalhon N, Prey S, Robert C, Vabres P, Lebbe C, Meyer N, Basset-Seguin N.

J Clin Oncol. 2019 Dec 1;37(34):3275-3282. doi: 10.1200/JCO.18.00794. Epub 2019 Oct 14.

PMID:
31609670
25.

Does the Latent Period of Leaf Fungal Pathogens Reflect Their Trophic Type? A Meta-Analysis of Biotrophs, Hemibiotrophs, and Necrotrophs.

Précigout PA, Claessen D, Makowski D, Robert C.

Phytopathology. 2020 Jan 3:PHYTO04190144R. doi: 10.1094/PHYTO-04-19-0144-R. [Epub ahead of print]

PMID:
31577162
26.

Hospital Outcomes in Antepartum Mental Disorders: A Study on 897,397 Pregnant Inpatients.

Bhimanadham NN, Mainali P, Robert CA, Masroor A, Onyeaka HK, Hossain S, Patel RS.

Behav Sci (Basel). 2019 Sep 29;9(10). pii: E105. doi: 10.3390/bs9100105.

27.

BRAF exon 11 mutant melanoma and sensitivity to BRAF/MEK inhibition: Two case reports.

Melin A, Routier E, Tissot H, Rouleau E, Robert C.

Eur J Cancer. 2019 Nov;121:109-112. doi: 10.1016/j.ejca.2019.08.029. Epub 2019 Sep 27. No abstract available.

PMID:
31569065
28.

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review.

Abbas MK, Zaidi ARZ, Robert CA, Thiha S, Malik BH.

Cureus. 2019 Sep 4;11(9):e5563. doi: 10.7759/cureus.5563. Review.

29.

Revealing exciton masses and dielectric properties of monolayer semiconductors with high magnetic fields.

Goryca M, Li J, Stier AV, Taniguchi T, Watanabe K, Courtade E, Shree S, Robert C, Urbaszek B, Marie X, Crooker SA.

Nat Commun. 2019 Sep 13;10(1):4172. doi: 10.1038/s41467-019-12180-y.

30.

Entomopathogenic nematodes increase predation success by inducing cadaver volatiles that attract healthy herbivores.

Zhang X, Machado RA, Doan CV, Arce CC, Hu L, Robert CA.

Elife. 2019 Sep 11;8. pii: e46668. doi: 10.7554/eLife.46668.

31.

Estrous cycle impacts miRNA content in extracellular vesicles that modulate bovine cumulus cell transcripts during in vitro maturation.

de Ávila ACFCM, Bridi A, Andrade GM, Del Collado M, Sangalli JR, Nociti RP, da Silva Junior WA, Bastien A, Robert C, Meirelles FV, Perecin F, da Silveira JC.

Biol Reprod. 2019 Sep 2. pii: ioz177. doi: 10.1093/biolre/ioz177. [Epub ahead of print]

PMID:
31504242
32.

Control of the Exciton Radiative Lifetime in van der Waals Heterostructures.

Fang HH, Han B, Robert C, Semina MA, Lagarde D, Courtade E, Taniguchi T, Watanabe K, Amand T, Urbaszek B, Glazov MM, Marie X.

Phys Rev Lett. 2019 Aug 9;123(6):067401. doi: 10.1103/PhysRevLett.123.067401.

PMID:
31491178
33.

Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management.

Gogas HJ, Flaherty KT, Dummer R, Ascierto PA, Arance A, Mandala M, Liszkay G, Garbe C, Schadendorf D, Krajsova I, Gutzmer R, Sileni VC, Dutriaux C, de Groot JWB, Yamazaki N, Loquai C, Gollerkeri A, Pickard MD, Robert C.

Eur J Cancer. 2019 Sep;119:97-106. doi: 10.1016/j.ejca.2019.07.016. Epub 2019 Aug 19.

34.

Mediator in the Embryo-endometrium Cross-talk: Granulocyte Colony-stimulating Factor in Infertility.

Robert CA, Abbas MK, Zaidi ARZ, Thiha S, Malik BH.

Cureus. 2019 Aug 15;11(8):e5390. doi: 10.7759/cureus.5390. Review.

35.

Risk-based stratification in head and neck mucosal melanoma.

Moya-Plana A, Mangin D, Dercle L, Taouachi R, Casiraghi O, Ammari S, Nguyen F, Temam S, Robert C, Gorphe P.

Oral Oncol. 2019 Oct;97:44-49. doi: 10.1016/j.oraloncology.2019.07.026. Epub 2019 Aug 10.

PMID:
31421470
36.

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.

Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, Vaysse T, Marthey L, Eggermont A, Asvatourian V, Lanoy E, Mateus C, Robert C, Carbonnel F.

Ann Oncol. 2019 Dec 1;30(12):2012. doi: 10.1093/annonc/mdz224. No abstract available.

PMID:
31408090
37.

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.

Long GV, Flaherty KT, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Chiarion-Sileni V, Lebbe C, Mandalá M, Millward M, Arance A, Bondarenko I, Haanen JBAG, Hansson J, Utikal J, Ferraresi V, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane SR, Legos JJ, Mookerjee B, Grob JJ.

Ann Oncol. 2019 Nov 1;30(11):1848. doi: 10.1093/annonc/mdz221. No abstract available.

38.

Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis.

Badin RA, Binley K, Van Camp N, Jan C, Gourlay J, Robert C, Gipchtein P, Fayard A, Stewart H, Ralph GS, Lad Y, Kelleher M, Loader J, Hosomi K, Palfi S, Mitrophanous KA, Hantraye P.

Mol Ther Methods Clin Dev. 2019 Jul 16;14:206-216. doi: 10.1016/j.omtm.2019.07.002. eCollection 2019 Sep 13.

39.

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.

Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbe C, Ferraresi V, Smylie M, Weber JS, Maio M, Hosein F, de Pril V, Kicinski M, Suciu S, Testori A.

Eur J Cancer. 2019 Sep;119:1-10. doi: 10.1016/j.ejca.2019.07.001. Epub 2019 Aug 7.

PMID:
31400634
40.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.

Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, De Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M; Groupe de Cancérologie Cutanée, Groupe Français de Pneumo-Cancérologie, and Club Rhumatismes et Inflammations.

Arthritis Rheumatol. 2019 Dec;71(12):2100-2111. doi: 10.1002/art.41068. Epub 2019 Oct 21.

PMID:
31379105
41.

Self-medication in pain management: The state of the art of pharmacists' role for optimal Over-The-Counter analgesic use.

Perrot S, Cittée J, Louis P, Quentin B, Robert C, Milon JY, Bismut H, Baumelou A.

Eur J Pain. 2019 Nov;23(10):1747-1762. doi: 10.1002/ejp.1459. Epub 2019 Aug 7. Review.

PMID:
31349370
42.

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.

Seban RD, Nemer JS, Marabelle A, Yeh R, Deutsch E, Ammari S, Moya-Plana A, Mokrane FZ, Gartrell RD, Finkel G, Barker L, Bigorgne AE, Schwartz LH, Saenger Y, Robert C, Dercle L.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2298-2310. doi: 10.1007/s00259-019-04411-7. Epub 2019 Jul 25.

PMID:
31346755
43.

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.

Robert C, Ribas A, Schachter J, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil CM, Lotem M, Larkin JMG, Lorigan P, Neyns B, Blank CU, Petrella TM, Hamid O, Su SC, Krepler C, Ibrahim N, Long GV.

Lancet Oncol. 2019 Sep;20(9):1239-1251. doi: 10.1016/S1470-2045(19)30388-2. Epub 2019 Jul 22.

PMID:
31345627
44.

Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.

Schwarzinger M, Luchini S; EPICORL Study Group.

Health Qual Life Outcomes. 2019 Jul 25;17(1):129. doi: 10.1186/s12955-019-1195-9.

45.

Acute pancreatitis after vismodegib for basal cell carcinoma: a causal relation?

Velter C, Blanc J, Robert C.

Eur J Cancer. 2019 Sep;118:67-69. doi: 10.1016/j.ejca.2019.06.010. Epub 2019 Jul 17. No abstract available.

PMID:
31325874
46.

Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance.

Akindigh TM, Joseph AO, Robert CO, Okojokwu OJ, Okechalu JN, Anejo-Okopi JA.

Afr J Lab Med. 2019 Jun 27;8(1):622. doi: 10.4102/ajlm.v8i1.622. eCollection 2019.

47.

Utility of enhanced CT for patients with suspected uncomplicated renal colic and no acute findings on non-enhanced CT.

Robert C, Gandon Y, Peyronnet B, Gauthier S, Aubé C, Paisant A.

Clin Radiol. 2019 Oct;74(10):813.e11-813.e18. doi: 10.1016/j.crad.2019.06.007. Epub 2019 Jul 9.

PMID:
31300208
48.

Unraveling the effects of the gut microbiota composition and function on horse endurance physiology.

Plancade S, Clark A, Philippe C, Helbling JC, Moisan MP, Esquerré D, Moyec LL, Robert C, Barrey E, Mach N.

Sci Rep. 2019 Jul 3;9(1):9620. doi: 10.1038/s41598-019-46118-7.

49.

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.

Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV.

Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Review.

PMID:
31267972
50.

A First Step Toward Unraveling the Energy Metabolism in Endurance Horses: Comparison of Plasma Nuclear Magnetic Resonance Metabolomic Profiles Before and After Different Endurance Race Distances.

Le Moyec L, Robert C, Triba MN, Bouchemal N, Mach N, Rivière J, Zalachas-Rebours E, Barrey E.

Front Mol Biosci. 2019 Jun 12;6:45. doi: 10.3389/fmolb.2019.00045. eCollection 2019.

Supplemental Content

Loading ...
Support Center